Daidone MG - Search Results

1

Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.

Cappelletti V, Veneroni S, Coradini D, Oriana S, Tomasic G, Younes M, Daidone MG. Cappelletti V, et al. Among authors: daidone mg. J Natl Cancer Inst. 2003 Apr 16;95(8):629-30. doi: 10.1093/jnci/95.8.629. J Natl Cancer Inst. 2003. PMID: 12697859 No abstract available.

2

Limits of predictive models using microarray data for breast cancer clinical treatment outcome.

Reid JF, Lusa L, De Cecco L, Coradini D, Veneroni S, Daidone MG, Gariboldi M, Pierotti MA. Reid JF, et al. Among authors: daidone mg. J Natl Cancer Inst. 2005 Jun 15;97(12):927-30. doi: 10.1093/jnci/dji153. J Natl Cancer Inst. 2005. PMID: 15956654

3

Strategies to translate preclinical information to breast cancer patient benefit.

Daidone MG, Zaffaroni N, Cappelletti V. Daidone MG, et al. J Natl Cancer Inst Monogr. 2011;2011(43):55-9. doi: 10.1093/jncimonographs/lgr033. J Natl Cancer Inst Monogr. 2011. PMID: 22043041

4

Estrogen receptor-beta expression in hereditary breast cancer.

Daidone MG, Veneroni S, Cappelletti V, Radice P, Pierotti MA, Younes M. Daidone MG, et al. J Clin Oncol. 2002 Sep 1;20(17):3752-3; author reply 3753. doi: 10.1200/JCO.2002.99.116. J Clin Oncol. 2002. PMID: 12202682 No abstract available.

5

Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women.

Daidone MG, Luisi A, Martelli G, Benini E, Veneroni S, Tomasic G, De Palo G, Silvestrini R. Daidone MG, et al. Br J Cancer. 2000 Jan;82(2):270-7. doi: 10.1054/bjoc.1999.0914. Br J Cancer. 2000. PMID: 10646876 Free PMC article.

6

Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen.

Coradini D, Biganzoli E, Pellizzaro C, Veneroni S, Oriana S, Ambrogi F, Erdas R, Boracchi P, Daidone MG, Marubini E. Coradini D, et al. Among authors: daidone mg. Br J Cancer. 2003 Jul 21;89(2):268-70. doi: 10.1038/sj.bjc.6601060. Br J Cancer. 2003. PMID: 12865915 Free PMC article. Clinical Trial.

7

Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patients.

Zambetti M, Bonadonna G, Valagussa P, Daidone MG, Coradini D, Bignami P, Contesso G, Silvestrini R. Zambetti M, et al. Among authors: daidone mg. J Natl Cancer Inst Monogr. 1992;(11):77-83. J Natl Cancer Inst Monogr. 1992. PMID: 1627434 Clinical Trial.

8

p53 as an independent prognostic marker in lymph node-negative breast cancer patients.

Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U. Silvestrini R, et al. Among authors: daidone mg. J Natl Cancer Inst. 1993 Jun 16;85(12):965-70. doi: 10.1093/jnci/85.12.965. J Natl Cancer Inst. 1993. PMID: 8496982

9

Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen.

Coradini D, Gariboldi M, Fedeli M, Pierotti MA, Daidone MG. Coradini D, et al. Among authors: daidone mg. Breast Cancer Res Treat. 2008 Sep;111(2):389-90. doi: 10.1007/s10549-007-9777-3. Epub 2007 Oct 4. Breast Cancer Res Treat. 2008. PMID: 17914668 No abstract available.

10

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F, Veronesi U. Silvestrini R, et al. Among authors: daidone mg. J Natl Cancer Inst. 1994 Apr 6;86(7):499-504. doi: 10.1093/jnci/86.7.499. J Natl Cancer Inst. 1994. PMID: 8133533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters